Meet the individuals that make the Roberts Lab what it is. Together, we work to understand biological modifications and identify disease biomarkers. Read below for more information on our wonderful team.
Blaine R. Roberts, PhD Associate Professor and Principal Investigator
Dr. Roberts is an Associate Professor in the Department of Biochemistry and Department of Neurology at Emory University. He obtained his Bachelor of Science in Chemistry at Montana State University and his PhD in Biochemistry and Biophysics from Oregon State University.
Anne completed her B.S. at Oregon State University. She has expertise in Bioanalytical chemistry with particular emphasis on proteomics (large format 2D gels, LC-MS), and metal analysis (ICP-MS). She has expertise in handling large number of (>1,000) samples for bioanalytical measurement. She has excellent organizational skills. She is also passionate about training the next generation of scientist including undergraduate, graduate students, post-doctoral fellows and anyone willing to learn. She is working to understand the root cause of Alzheimer’s, Parkinson’s and ALS.
Madison obtained her B.S. in microbiology at Texas A&M University. She has experience in immunohistochemistry and MALDI imaging. She also runs and maintains our Quanterix HDX system and has expertise in developing homemade assays on the Quanterix and MesoScale Discovery systems. She is working to characterize blood and brain based biomarkers of neurodegenerative
Dr. Nazaar earned her B.Sc. in Chemistry at the University of Peradeniya, Sri Lanka. She then completed her Ph.D. at Michigan State U. where she studied the folding, stability and degradation of membrane proteins. She has expertise in the development and application of lipidomic and proteomics assays in human plasma and red blood cells with the goal of developing a biomarker for Parkinson’s disease. She has expertise in using the TIMS TOF LC-MS system (Bruker) and data analysis including MSDIAL, Skyline and Metaboscape.
Lester completed his B.S He is working passionately to understand what causes ALS and how the compound CuATSM functions to treat the neurodegenerative disease.